Primary Percutaneous Coronary Intervention

Size: px
Start display at page:

Download "Primary Percutaneous Coronary Intervention"

Transcription

1 The big 5 in PCI Primary Percutaneous Coronary Intervention W. Wijns (Aalst, BE)

2 Disclosures Consulting Fees: on my behalf go to the Cardiovascular Research Center Aalst Contracted Research between the Cardiovascular Research Center Aalst and several pharmaceutical and device companies Ownership Interest: Cardiovascular Research Center Aalst is co-founder of Cardio³BioSciences (cell-based regeneration cardiovascular therapies) Chairman of PCR / EuroPCR, the annual Course of EAPCI

3 Primary Percutaneous Coronary Intervention for STEMI The evidence The procedure The network

4 1 ary PCI for STEMI: historical landmarks Late 70 ies Intracoronary streptokinase 1980 Wiring and first balloon attempts 80 ies Zwolle and PAMI studies 1993 Illusion of reperfusion (Lincoff, Topol) 2002 First meta-analyses PCI vs lysis 2003 PPCI recommended by ESC Guidelines 2008 Aspiration catheters (TAPAS) 2010 New antiplatelet drugs for PCI 2012 Implementation projects (SFL, NIAP)

5 Reperfusion Therapy for STEMI 23 Randomized Trials (n=7739) Pooled Analysis - Outcome at 30 days DEATH PCI Better Lysis Better n = 3872 n = % 9% 12 9 Pooled Analysis: PCI vs Lytics Mortality (%) at 30 days Lytics PCI 12.1 Re-MI STROKE COMBINED 3% 7% 1% 2% 8% 14% OR (95% C.I) P< Early <2h Medium 2-4h Late >4h Keeley et al. Lancet 2003 Zijlstra et al. Eur Heart J 2002 Courtesy dr. H. Suryapranata

6 Symptom-To-Balloon and One-year Mortality (%) Every minute delay counts both for thrombolysis and primary PCI < 2 h 2-4 h 4-6 h > 6 h P = P = NS De Luca et al JACC 2003 De Luca et al Circulation 2004 Courtesy dr. H. Suryapranata P = All Patients Low-Risk High-Risk n=1791 n=545 n= Adjusted RR [95% CI] [ ] RR death increased by 7.5% for each 30-min 60 Y = 2.86 (+ 1.46) X X 2 p < Ischemic Time (min) 360

7 PCI Volume and Outcome In 2003, patients at 67 non-university hospitals: ALKK PCI registry In Hospital Mortality for PCI No MI STEMI / NSTEMI Zahn et al. Heart 2008;94:329 35

8 Primary Percutaneous Coronary Intervention for STEMI The evidence The procedure The network

9 7 Leads for improved procedural outcomes after Primary PCI Adjunctive pharmacotherapy Thrombus management Access site selection Reduction in bleeding complications Stent choices Strategies for multivessel management Myocardial preservation

10 Available data with 1 st generation & newer DES Long-term safety and efficacy of DES vs BMS in pts with STEMI (Piccolo et al. Atherosclerosis 2011;217:149) 10 studies, pts, follow-up 3.6 years Stent thrombosis OR 1.06 p = 0.66 Very late ST OR 1.71 p = 0.03 TVR OR 0.51 p < Performance of newer generation DES is superior, especially in terms of deliver-ability and safety Examination Everolimus-DES vs BMS Comfortable AMI Biolimus-DES vs BMS

11 MACE (%) COMFORTABLE AMI Primary Endpoint 1 Year yr HR 0.49 ( ) P=0.004 BMS 8.7 % 4 2 BES 4.3 % 0 No at risk BMS BES Days since index procedure MACE* = Cardiac death + TVR-MI + ischemic TLR L. Räber et al. JAMA 2012;308:777

12 Multivessel PCI during Primary PCI for STEMI PRO Aiming at complete revascularisation Convenience (no need for repeat procedures) Few positive studies including undersized RCT CONTRA Increased procedural risk Acute ischemic risk / prothrombotic milieu Acute dysfunction Closing the door for surgery Benefit uncertain (contradictory metanalyses)

13 FFR in ACS V. B. 83-y-o man, acute anterior MI, Chronic Renal Failure

14 FFR in ACS V. B. 83-y-o man, acute anterior MI, Chronic Renal Failure Possible Stategies 1. Stent the non culprit distal RCA and the LCx in the same setting? 2. Bring the patient back to the cath lab in 4 to 8 days? 3. Elective non-invasive assessment in the next coming days?

15 FFR in ACS FFR in Non-Culprit Stenoses During the Acute Phase of a Myocardial Infarction patients with acute MI 112 non-culprit stenoses FFR - acute phase AND - 1 month later In 2/112 stenoses, the FFR value was >0.80 at the acute phase but <0.75 at follow-up ACUTE FOLLOW-UP p=ns Ntalianis A et al JACC interv 2010

16 FFR in ACS V. B. 83-y-o man, acute anterior MI, Chronic Renal Failure Non Culprit 1 Non Culprit 2

17 Primary Percutaneous Coronary Intervention for STEMI The evidence The procedure The network

18 Reperfusion Therapy for STEMI 25 % STEMI Mortality Rates in The Netherlands Cardiovascular Mortality Europe (From: Closing the health gap in European Union. Ed. by W. Zatonski) Thrombolysis P-PCI Pre-CCU CCU Reperfusion Era Central Bureau of Statistics Courtesy dr. H. Suryapranata

19 Widimsky et al, Eur Heart J, 2010;31: Reperfusion therapy in Europe 100% 90% 80% 70% 60% 50% 40% 30% 20% 10% 0% CZ SLO DE CH NO DK PL HR SE HU BE IL IT FIN AT FR SK ES LAT UK BG PO SRB GR TR RO P-PCI Thrombolysis No reperfusion

20 Primary PCI per million vs Gross Domestic Product NO relationship between Country GDP & Primary PCI rate

21

22 Sremska Kamenica (2 cath labs) Belgrade (8 + 4) Arrival to cath lab <90 minutes for large infarctions and young patients ` Kragujevac (1) < 120 minutes for others STEMI Guidelines (Van de Werf at al, EHJ 2008) Not able to arrive to cath lab in 120 min: inhab. (12 %) Niš (2) ACC/AHA 2007 STEMI Guideline Focused Update Not able to arrive to cath lab in 90 min: inhab. (20 %) 2002 census

23 Organization of STEMI patient disposal describing pre- and in-hospital management, and reperfusion strategies within 12 h of First Medical Contact (FMC) Symptoms of STEMI EMS GP / Cardiologist Self referral Pre-hospital diagnosis & care Ambulance to Cath Primary PCI capable centre Private transportation Non-primary PCI capable centre PCI possible < 2 h Primary PCI no Rescue PCI no yes Successful fibrinolysis? Transfer to ICU of PCI-capable centre Immediate fibrinolysis Coronary Angiography 3 to 24 h after FMC Delayed PCI as required Joint 2010 ESC - EACTS Guidelines on Myocardial Revascularisation

24 NORWAY Prehospital treatment 4.8 mill with people fibrinolysis is used in areas with long transfer delays to PCI km km from N to S 7 PCI hospitals Long transfer times to PCI (>2 h) in: Mountains Islands Fjords Sparsely populated areas Unstable weather conditions PCI-hospital

25

26 1 ary PCI for STEMI: Take Home Don t miss the detailed presentation of the new 2012 ESC Guidelines for STEMI Aug 27, 8:30 1 ary PCI for STEMI is life-saving 1 ary PCI procedures ~ 30% of cathlab workload in good networks Among the big 5 Primary PCI for STEMI is the biggest!

Stent For Life, Egypt A Success Story. Hany Ragy MD, FSCAI NHI, Cairo,

Stent For Life, Egypt A Success Story. Hany Ragy MD, FSCAI NHI, Cairo, Stent For Life, Egypt A Success Story Hany Ragy MD, FSCAI NHI, Cairo, Egypt @hragy Stent For Life Initiative in Egypt Professor Mohamed Sobhy, MD, FACC, FESC Professor of Cardiology Department, Alexandria

More information

Relations of Interest

Relations of Interest Relations of Interest Consulting Fees on my behalf go to the Cardiovascular Research Center Aalst Contracted Research between the Cardiovascular Research Center Aalst and several pharmaceutical and device

More information

Patient Transfer. Mark de Belder The James Cook University Hospital Middlesbrough

Patient Transfer. Mark de Belder The James Cook University Hospital Middlesbrough Patient Transfer Mark de Belder The James Cook University Hospital Middlesbrough Current Management Strategies for ACS ACS No ST Elevation ST ST Elevation Elevation Early Invasive Early Conservative Fibrinolysis

More information

Current Advances and Best Practices in Acute STEMI Management A pharmacoinvasive approach

Current Advances and Best Practices in Acute STEMI Management A pharmacoinvasive approach Current Advances and Best Practices in Acute STEMI Management A pharmacoinvasive approach Frans Van de Werf, MD, PhD University Hospitals, Leuven, Belgium Frans Van de Werf: Disclosures Research grants

More information

I have no financial relationships to disclose

I have no financial relationships to disclose I have no financial relationships to disclose Networking decreases mortality Vasil Velchev,MD,PhD UH St. Anna Sofia time = myocardium = life Transfer for angioplasty vs. Immediate Thrombolysis (hospital

More information

The Window for Fibrinolysis. Frans Van de Werf, MD, PhD Leuven, Belgium

The Window for Fibrinolysis. Frans Van de Werf, MD, PhD Leuven, Belgium The Window for Fibrinolysis Frans Van de Werf, MD, PhD Leuven, Belgium ESC STEMI Guidelines : December 2008 Reperfusion Therapy: Fibrinolytic Therapy Recommendations Class LOE In the absence of contraindications

More information

Recommendations for criteria for STEMI systems of care: A focus on pharmacoinvasive strategies

Recommendations for criteria for STEMI systems of care: A focus on pharmacoinvasive strategies Recommendations for criteria for STEMI systems of care: A focus on pharmacoinvasive strategies Mohammad Zubaid, MB, ChB, FRCPC, FACC Professor of Medicine, Kuwait University Chairman, Faculty of Cardiology,

More information

Stent for Life Initiative. Portugal

Stent for Life Initiative. Portugal Stent for Life Initiative Portugal Hélder Pereira, MD, FESC, FACC SFL Portugal Champion, APIC Secretary Department of Cardiology Hospital Garcia de Orta, Almada, Portugal Annual Incidence of Primary PCIs

More information

Pharmaco-Invasive Approach for STEMI

Pharmaco-Invasive Approach for STEMI Pharmaco-Invasive Approach for STEMI Michael C. Kontos, MD Medical Director, Coronary Intensive Care Unit Director, Chest Pain Evaluation Center Associate Professor Departments of Internal Medicine (Cardiology),

More information

SHOULD A REGIONAL STEMI CENTRE ONLY OFFER PRIMARY PCI?

SHOULD A REGIONAL STEMI CENTRE ONLY OFFER PRIMARY PCI? SHOULD A REGIONAL STEMI CENTRE ONLY OFFER PRIMARY PCI? Kurt Huber, MD 3 Department of Internal Medicine, Cardiology and Intensive Care Medicine, Wilhelminenhospital, Vienna, Austria Disclosures DISCLOSURE

More information

What is new in the Treatment of STEMI? Malcolm R. Bell, MBBS Mayo Clinic Rochester, MN

What is new in the Treatment of STEMI? Malcolm R. Bell, MBBS Mayo Clinic Rochester, MN What is new in the Treatment of STEMI? Malcolm R. Bell, MBBS Mayo Clinic Rochester, MN October 2011 Part 2 Summary of newer antithrombotic and antiplatelet agents in STEMI Role of thrombectomy in PPCI

More information

Frans Van de Werf, MD, PhD Leuven, Belgium

Frans Van de Werf, MD, PhD Leuven, Belgium STEMI Cases and the ESC STEMI Guidelines Frans Van de Werf, MD, PhD Leuven, Belgium The Easy Case 2/21/2011 History and Risk Factors 50-year old male patient Past medical history: Teratoma right testis

More information

Updated and Guideline Based Treatment of Patients with STEMI

Updated and Guideline Based Treatment of Patients with STEMI Updated and Guideline Based Treatment of Patients with STEMI Eli I. Lev, MD Director, Cardiac Catheterization Laboratory Hasharon Hospital, Rabin Medical Center Associate Professor of Cardiology Tel-Aviv

More information

DECLARATION OF CONFLICT OF INTEREST

DECLARATION OF CONFLICT OF INTEREST DECLARATION OF CONFLICT OF INTEREST Multivessel disease and cardiogenic shock: CABG is the optimal revascularization therapy. Contra Prof. Christian JM Vrints Cardiogenic Shock Spiral Acute Myocardial

More information

Clinical Seminar. Which Diabetic Patient is a Candidate for Percutaneous Coronary Intervention - European Perspective

Clinical Seminar. Which Diabetic Patient is a Candidate for Percutaneous Coronary Intervention - European Perspective Clinical Seminar Which Diabetic Patient is a Candidate for Percutaneous Coronary Intervention - European Perspective Stephan Windecker Department of Cardiology Swiss Cardiovascular Center and Clinical

More information

Facilitated Percutaneous Coronary Intervention in Acute Myocardial Infarction. Is it beneficial to patients?

Facilitated Percutaneous Coronary Intervention in Acute Myocardial Infarction. Is it beneficial to patients? Facilitated Percutaneous Coronary Intervention in Acute Myocardial Infarction Is it beneficial to patients? Seung-Jea Tahk, MD. PhD. Suwon, Korea Facilitated PCI.. background Degree of coronary flow at

More information

FFR-guided Complete vs. Culprit Only Revascularization in AMI Patients Ki Hong Choi, MD On Behalf of FRAME-AMI Investigators

FFR-guided Complete vs. Culprit Only Revascularization in AMI Patients Ki Hong Choi, MD On Behalf of FRAME-AMI Investigators FFR-guided Complete vs. Culprit Only Revascularization in AMI Patients Ki Hong Choi, MD On Behalf of FRAME-AMI Investigators Heart Vascular Stroke Institute, Samsung Medical Center, Seoul, Republic of

More information

Critics of Thrombolytics: Is Pre-Hospital Clot-busting Actually a Bad Thing? David Persse, MD Houston Fire Department EMS

Critics of Thrombolytics: Is Pre-Hospital Clot-busting Actually a Bad Thing? David Persse, MD Houston Fire Department EMS Critics of Thrombolytics: Is Pre-Hospital Clot-busting Actually a Bad Thing? David Persse, MD Houston Fire Department EMS STEMI Stuff New or Recurrent MI s in U.S.: 865,000 Acute STEMI s: 500,000 Sooner

More information

Lessons learned From The National PCI Registry

Lessons learned From The National PCI Registry Lessons learned From The National PCI Registry w a v e On Behalf of The Publication Committee of the National PCI Registry Objectives & Anticipated Achievements To determine the epidemiology of patients

More information

Decision for fibrinolysis or primary PCI in the prehospital phase

Decision for fibrinolysis or primary PCI in the prehospital phase Decision for fibrinolysis or primary PCI in the prehospital phase Nicolas Danchin, Hôpital Européen Georges Pompidou, Paris, France Disclosures Research grants: Astrazeneca, Eli-Lilly, GSK, Merck, Novartis,

More information

Management of Cardiogenic shock. Prof. Christian JM Vrints

Management of Cardiogenic shock. Prof. Christian JM Vrints Management of Cardiogenic shock Prof. Christian JM Vrints none conflicts Management of Cardiogenic Shock Incidence and trends Importance of early revascularization Multivessel disease Left main disease

More information

Treatment of ST-elevation myocardial infarction in China: Where are we?

Treatment of ST-elevation myocardial infarction in China: Where are we? Treatment of ST-elevation myocardial infarction in China: Where are we? Associate Professor, Yihong Sun, MD Peking University People s Hospital Beijing, China Disclosure conflict of Interest The Challenges

More information

STEMI update. Vijay Krishnamoorthy M.D. Interventional Cardiology

STEMI update. Vijay Krishnamoorthy M.D. Interventional Cardiology STEMI update Vijay Krishnamoorthy M.D. Interventional Cardiology OVERVIEW Current Standard of Care in Management of STEMI Update in management of STEMI Pre-Cath Lab In the ED/Office/EMS. Cath Lab Post

More information

Approach to Multi Vessel disease with STEMI

Approach to Multi Vessel disease with STEMI Approach to Multi Vessel disease with STEMI MANAGEMENT OF ST-ELEVATION MYOCARDIAL INFARCTION Dr. Thomas Alexander, M.D; D.M; F.A.C.C. Senior Consultant and Interventional Cardiologist Kovai Medical Centre

More information

Management of STEMI in era of Reperfusion. Eagles Peter Moyer, MD, MPH Medical Director Boston EMS, Fire and Police

Management of STEMI in era of Reperfusion. Eagles Peter Moyer, MD, MPH Medical Director Boston EMS, Fire and Police Management of STEMI in era of Reperfusion Eagles 2007 Peter Moyer, MD, MPH Medical Director Boston EMS, Fire and Police STEMI in US ST Segment Elevation Myocardial Infarction (STEMI) ~500 K per year Thrombolysis

More information

PCI Update Qesaria 2009

PCI Update Qesaria 2009 PCI Update Qesaria 2009 Amit Segev Interventional Cardiology Chaim Outline Primary PCI Non-ST elevation ACS Multi-vessel disease Hemodynamic assessment of borderline lesions - FFR Stable AP Non-coronary

More information

STREAM - ONE YEAR MORTALITY STRATEGIC REPERFUSION EARLY AFTER MYOCARDIAL INFARCTION. STREAM 1Y AHA 2013 P Sinnaeve

STREAM - ONE YEAR MORTALITY STRATEGIC REPERFUSION EARLY AFTER MYOCARDIAL INFARCTION. STREAM 1Y AHA 2013 P Sinnaeve STREAM - ONE YEAR MORTALITY STRATEGIC REPERFUSION EARLY AFTER MYOCARDIAL INFARCTION PCI Hospital Ambulance/ER STREAM design STEMI

More information

Effect of upstream clopidogrel treatment in patients with ST-segment elevation myocardial infarction undergoing primary PCI

Effect of upstream clopidogrel treatment in patients with ST-segment elevation myocardial infarction undergoing primary PCI Effect of upstream clopidogrel treatment in patients with ST-segment elevation myocardial infarction undergoing primary PCI Dr Sasha Koul, MD Dept of Cardiology, Lund University Hospital, Lund, Sweden

More information

Cindy L. Grines MD FACC FSCAI

Cindy L. Grines MD FACC FSCAI Cindy L. Grines MD FACC FSCAI Hofstra Northwell School of Medicine Chair, Cardiology Academic Chief of Cardiology, Northwell Health North Shore University Hospital, Manhasset NY Multivessel Disease in

More information

What oral antiplatelet therapy would you choose? a) ASA alone b) ASA + Clopidogrel c) ASA + Prasugrel d) ASA + Ticagrelor

What oral antiplatelet therapy would you choose? a) ASA alone b) ASA + Clopidogrel c) ASA + Prasugrel d) ASA + Ticagrelor 76 year old female Prior Hypertension, Hyperlipidemia, Smoking On Hydrochlorothiazide, Atorvastatin New onset chest discomfort; 2 episodes in past 24 hours Heart rate 122/min; BP 170/92 mm Hg, Killip Class

More information

CLINICAL CONSEQUENCES OF THE

CLINICAL CONSEQUENCES OF THE CLINICAL CONSEQUENCES OF THE FAME STUDY TCT ASIA Seoul, Korea, april 26 th, 2012 Nico H. J. Pijls, MD, PhD Catharina Hospital, Eindhoven, The Netherlands GUIDELINES ESC SEPTEMBER 2010 FFR UPGRADED TO LEVEL

More information

DECLARATION OF CONFLICT OF INTEREST. Lecture fees: AstraZeneca, Ely Lilly, Merck.

DECLARATION OF CONFLICT OF INTEREST. Lecture fees: AstraZeneca, Ely Lilly, Merck. DECLARATION OF CONFLICT OF INTEREST Lecture fees: AstraZeneca, Ely Lilly, Merck. Risk of stopping dual therapy. S D Kristensen, FESC Aarhus Denmark Acute coronary syndrome: coronary thrombus Platelets

More information

Thrombus Aspiration before PCI: Routine Mandatory. Professor Clinical Cardiology Academic Medical Center University of Amsterdam

Thrombus Aspiration before PCI: Routine Mandatory. Professor Clinical Cardiology Academic Medical Center University of Amsterdam Seoul, 27 April TCT AP 2010 Thrombus Aspiration before PCI: Routine Mandatory Robbert J de Winter MD PhD FESC Professor Clinical Cardiology Academic Medical Center University of Amsterdam AMC Amsterdam

More information

STEMI Primary Percutaneous Coronary Intervention

STEMI Primary Percutaneous Coronary Intervention STEMI Primary Percutaneous Coronary Intervention Abdul Razek Maaty, MD Professor of Medicine Outline Primary PCI Aspiration, manual thrombectomy and distal protection devices Choice of stent Pharmacothaerpy,

More information

Controversies on Primary angioplasty in STEMI

Controversies on Primary angioplasty in STEMI Controversies on Primary angioplasty in STEMI 원주의대이승환 Case ( 51/M) CC C.C: ongoing squeezing chest pain D : for 2 hours Risk factors Current smoker ( 40 PYs) Hypercholesterolemia (+) Case ( 51/M) Physical

More information

The role of pre hospital thrombolysis. Aaron Frimerman Hillel Yaffe Medical Center Hadera Israel

The role of pre hospital thrombolysis. Aaron Frimerman Hillel Yaffe Medical Center Hadera Israel The role of pre hospital thrombolysis Aaron Frimerman Hillel Yaffe Medical Center Hadera Israel Is thrombolysis still valid? Disclosure I am an Interventional Cardiologist STEMI is mainly a thrombotic

More information

NEBRASKA STEMI CONFERENCE 2015 Dr. Doug Kosmicki. 2013, American Heart Association

NEBRASKA STEMI CONFERENCE 2015 Dr. Doug Kosmicki. 2013, American Heart Association NEBRASKA STEMI CONFERENCE 2015 Dr. Doug Kosmicki 2013, American Heart Association 1 Dr. Doug Kosmicki Reperfusion Strategies Disclosure Information Report any disclosure information of conflicts of interest.

More information

Target vessel only revascularization versus complet revascularization in non culprit lesions in acute myocardial infarction treated by primary PCI

Target vessel only revascularization versus complet revascularization in non culprit lesions in acute myocardial infarction treated by primary PCI Target vessel only revascularization versus complet revascularization in non culprit lesions in acute myocardial infarction treated by primary PCI Gamal Abdelhady, Emad Mahmoud Department of interventional

More information

Transfer in D2B. Scott D Friedman, MD FACC Medical Director, Cardiology Services Shore Health System of Maryland. The Problem

Transfer in D2B. Scott D Friedman, MD FACC Medical Director, Cardiology Services Shore Health System of Maryland. The Problem Transfer in D2B Scott D Friedman, MD FACC Medical Director, Cardiology Services Shore Health System of Maryland The Problem NRMI-5: North Carolina, July 2003- June 2004 NC Nation Guidelines N 2,738 79,927

More information

ACUTE CORONARY SYNDROME PCI IN THE ELDERLY

ACUTE CORONARY SYNDROME PCI IN THE ELDERLY ACUTE CORONARY SYNDROME PCI IN THE ELDERLY G.KARABELA MD.PhD ATHENS NAVAL HOSPITAL INTERVENTIONAL CARDIOLOGY DEPARTMENT NO CONFLICT OF INTEREST TO DECLAIRE Risk stratification in Αcute Coronary Syndrome.

More information

ACI London Thrombectomy in STEMI. is the evidence clear? Brad Higginson International marketing manager

ACI London Thrombectomy in STEMI. is the evidence clear? Brad Higginson International marketing manager ACI London 2010 Thrombectomy in STEMI is the evidence clear? Brad Higginson International marketing manager Options for Management of Thrombotic Lesions Pharmacologic Therapies Embolic Protection Devices

More information

COMPARE Trial Elvin Kedhi Maasstad Ziekenhuis Rotterdam The Netherlands

COMPARE Trial Elvin Kedhi Maasstad Ziekenhuis Rotterdam The Netherlands COMPARE Trial Elvin Kedhi Maasstad Ziekenhuis Rotterdam The Netherlands TCTAP 2010 Seoul, Korea Disclosures Research Foundation of the Cardiology Department has received unrestricted research grants from:

More information

New Insights on Reperfusion Choices Implications of STREAM. Paul W Armstrong MD

New Insights on Reperfusion Choices Implications of STREAM. Paul W Armstrong MD New Insights on Reperfusion Choices Implications of STREAM ESC STEMI Satellite Symposium August 31 2014 Aligning Optimal Care to Time Place and Person Paul W Armstrong MD Disclosure Statement Paul W. Armstrong

More information

Optimal antithrombotic therapy:

Optimal antithrombotic therapy: Optimal antithrombotic therapy: upstream and during primary PCI. Steen D Kristensen, MD, DMSc, FESC Professor and Consultant Interventional Cardiologist Aarhus University, Denmark UNIVERSITY OF AARHUS

More information

STEMI Stents What next? Arshad Khan - HNE Clinical Research Fellow. Supervisors: Prof Boyle and Attia.

STEMI Stents What next? Arshad Khan - HNE Clinical Research Fellow. Supervisors: Prof Boyle and Attia. STEMI Stents What next? Arshad Khan - HNE Clinical Research Fellow. Supervisors: Prof Boyle and Attia. PART 1 Systems of care for STEMI. STEMI Management Coronary angiogram +/- stenting. Prehospital thrombolysis

More information

Patient and System Time Delay

Patient and System Time Delay Quality Indicators in the Management of ST-elevation Myocardial Infarction Patient and System Time Delay Jacob Thorsted Sorensen, MD, PhD Department of Cardiology Aarhus University Hospital, Denmark Disclosures

More information

SYSTEMATIC MANUAL THROMBUS ASPIRATION: PRO

SYSTEMATIC MANUAL THROMBUS ASPIRATION: PRO SYSTEMATIC MANUAL THROMBUS ASPIRATION: PRO FRANCESCO BURZOTTA INSTITUTE OF CARDIOLOGY CATHOLIC UNIVERSITY OF THE SACRED HEART ROME, ITALY CONTROVERSIES IN PRIMARY PERCUTANEOUS CORONARY INTERVENTION ESC

More information

The top 5 trials in the last year: Ischemic Heart Disease

The top 5 trials in the last year: Ischemic Heart Disease The top 5 trials in the last year: Ischemic Heart Disease Malcolm R. Bell, MBBS, FRACP, FACC Vice Chair, Department of Cardiovascular Medicine Mayo Clinic, Rochester MN, USA 2018 MFMER 3718476-1 Conflicts

More information

Management of ST-elevation myocardial infarction Update 2009 Late comers: which options?

Management of ST-elevation myocardial infarction Update 2009 Late comers: which options? European Society of Cardiology Annual Session 2009 Management of ST-elevation myocardial infarction Update 2009 Late comers: which options? Antonio Abbate, MD Assistant Professor of Medicine Virginia Commonwealth

More information

Thrombectomy. how? For whom?

Thrombectomy. how? For whom? Thrombectomy how? For whom? Marco Zimarino, MD, PhD Institute of Cardiology - University G. d Annunzio, Chieti (Italy) Why Manual Thrombectomy? Pros 1 Extraction of thrombotic material, acute reduction

More information

Subsequent management and therapies

Subsequent management and therapies ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation Subsequent management and therapies Marco Valgimigli, MD, PhD University of Ferrara ITALY

More information

PCI for Left Main Coronary Artery Stenosis. Jean Fajadet Clinique Pasteur, Toulouse, France

PCI for Left Main Coronary Artery Stenosis. Jean Fajadet Clinique Pasteur, Toulouse, France PCI for Left Main Coronary Artery Stenosis Jean Fajadet Clinique Pasteur, Toulouse, France Athens, October 19, 2018 Left Main Coronary Artery Disease Significant unprotected left main coronary artery disease

More information

Culprit PCI vs MultiVessel PCI for Acute Myocardial Infarction

Culprit PCI vs MultiVessel PCI for Acute Myocardial Infarction Culprit PCI vs MultiVessel PCI for Acute Myocardial Infarction Dipti Itchhaporia, MD, FACC, FESC Trustee, American College of Cardiology Director of Disease Management, Hoag Hospital Robert and Georgia

More information

PROMUS Element Experience In AMC

PROMUS Element Experience In AMC Promus Element Luncheon Symposium: PROMUS Element Experience In AMC Jung-Min Ahn, MD. University of Ulsan College of Medicine, Heart Institute, Asan Medical Center, Seoul, Korea PROMUS Element Clinical

More information

Acute Coronary Syndrome

Acute Coronary Syndrome Acute Coronary Syndrome Clinical Manifestation of CAD Silent Ischemia/asymptomatic Stable Angina Acute Coronary Syndrome (Non- STEMI/UA and STEMI) Arrhythmias Heart Failure Sudden Death Pain patterns with

More information

Surgical vs. Percutaneous Revascularization in Patients with Diabetes and Acute Coronary Syndrome

Surgical vs. Percutaneous Revascularization in Patients with Diabetes and Acute Coronary Syndrome Surgical vs. Percutaneous Revascularization in Patients with Diabetes and Acute Coronary Syndrome Chris C. Cook, MD Associate Professor of Surgery Director, CT Residency Program, WVU ACOI 10/17/18 No Disclosures

More information

Technical Aspects and Clinical Indications of FFR

Technical Aspects and Clinical Indications of FFR Technical Aspects and Clinical Indications of FFR Emanuele Barbato, MD, PhD, FESC Cardiovascular Center Aalst - OLV Clinic Aalst, Belgium Potential conflicts of interest Consulting fees and honoraria on

More information

Improving STEMI outcomes in Denmark. Michael Rahbek Schmidt, MD, PhD. Aarhus University Hospital Skejby Denmark

Improving STEMI outcomes in Denmark. Michael Rahbek Schmidt, MD, PhD. Aarhus University Hospital Skejby Denmark Improving STEMI outcomes in Denmark Michael Rahbek Schmidt, MD, PhD. Aarhus University Hospital Skejby Denmark Presenter Disclosure Information Study funded by Fondation Leducq Michael Rahbek Schmidt The

More information

FRACTIONAL FLOW RESERVE: STANDARD OF CARE

FRACTIONAL FLOW RESERVE: STANDARD OF CARE FRACTIONAL FLOW RESERVE: FROM INVESTIGATIONAL TOOL TO STANDARD OF CARE TCT ASIA Seoul, Korea, april 26 th, 2012 Nico H. J. Pijls, MD, PhD Catharina Hospital, Eindhoven, The Netherlands FRACTIONAL FLOW

More information

How to approach non-infarct related artery disease in patients with STEMI in a limited resource setting

How to approach non-infarct related artery disease in patients with STEMI in a limited resource setting How to approach non-infarct related artery disease in patients with STEMI in a limited resource setting Ahmed A A Suliman, MBBS, FACP, FESC Associate Professor, University of Khartoum Interventional Cardiologist,

More information

Thrombolysis in Cardiology to whom? Professor Steen D. Kristensen, MD, DMSc, FESC Department of Cardiology

Thrombolysis in Cardiology to whom? Professor Steen D. Kristensen, MD, DMSc, FESC Department of Cardiology Thrombolysis in Cardiology to whom? Professor Steen D. Kristensen, MD, DMSc, FESC Department of Cardiology UNIVERSITY OF AARHUS 1 COI Speakers fee: Aspen, AZ, Bayer, BMS/Pfizer Departmental research grant:

More information

Optimal antiplatelet and anticoagulant therapy for patients treated in STEMI network

Optimal antiplatelet and anticoagulant therapy for patients treated in STEMI network Torino 6 Joint meeting with Mayo Clinic Great Innovation in Cardiology 14-15 Ottobre 2010 Optimal antiplatelet and anticoagulant therapy for patients treated in STEMI network Diego Ardissino Ischemic vs

More information

Meet the Guidelines Le principali novità che modificheranno la nostra pratica clinica: STEMI

Meet the Guidelines Le principali novità che modificheranno la nostra pratica clinica: STEMI Meet the Guidelines 2017. Le principali novità che modificheranno la nostra pratica clinica: STEMI Guido Parodi Cardiologia Interventistica AOU Sassari Scuola di Specializzazione in Malattie dell Apparato

More information

Benefit of Performing PCI Based on FFR

Benefit of Performing PCI Based on FFR Benefit of Performing PCI Based on FFR William F. Fearon, MD Associate Professor Director, Interventional Cardiology Stanford University Medical Center Benefit of FFR-Guided PCI FFR-Guided PCI vs. Angiography-Guided

More information

PPCI in STEMI. ESC at the 22nd Annual Conference of the Saudi Heart Association February 21th, 2011

PPCI in STEMI. ESC at the 22nd Annual Conference of the Saudi Heart Association February 21th, 2011 PPCI in STEMI Dr Hassan Mhish Interventional Cardiology Consultant Cardiology Fellowship Program Director Prince Salman Heart Center King Fahd Medical City Riyadh, KSA ESC at the 22nd Annual Conference

More information

Cover Page. The handle holds various files of this Leiden University dissertation

Cover Page. The handle  holds various files of this Leiden University dissertation Cover Page The handle http://hdl.handle.net/1887/21543 holds various files of this Leiden University dissertation Author: Dharma, Surya Title: Perspectives in the treatment of cardiovascular disease :

More information

STEMI AND MULTIVESSEL CORONARY DISEASE

STEMI AND MULTIVESSEL CORONARY DISEASE STEMI AND MULTIVESSEL CORONARY DISEASE ΤΣΙΑΦΟΥΤΗΣ Ν. ΙΩΑΝΝΗΣ ΕΠΕΜΒΑΤΙΚΟΣ ΚΑΡΔΙΟΛΟΓΟΣ Α ΚΑΡΔΙΟΛΟΓΙΚΗ ΝΟΣ ΕΡΥΘΡΟΥ ΣΤΑΥΡΟΥ IRA 30-50% of STEMI patients have additional stenoses other than the infarct related

More information

Focus on Acute Coronary Syndromes

Focus on Acute Coronary Syndromes Focus on Acute Coronary Syndromes Emanuele Barbato, MD, PhD, FESC Cardiovascular Center Aalst, Belgium Potential conflicts of interest Consulting fees and honoraria on my behalf go to the Cardiovascular

More information

Mark C. Bieniarz, MD Andrew Harrell, MD Peter Berger, MD

Mark C. Bieniarz, MD Andrew Harrell, MD Peter Berger, MD Mark C. Bieniarz, MD Andrew Harrell, MD Peter Berger, MD Should PCI center activate the cathlab off EMS field interpretation of ECG? Is this happening consistently in New Mexico? What is acceptable rate

More information

EXCEL vs. NOBLE: How to Treat Left Main Disease in 2017 AATS International Cardiovascular Symposium December 8-9, 2017

EXCEL vs. NOBLE: How to Treat Left Main Disease in 2017 AATS International Cardiovascular Symposium December 8-9, 2017 EXCEL vs. NOBLE: How to Treat Left Main Disease in 2017 AATS International Cardiovascular Symposium December 8-9, 2017 Igor F. Palacios, MD Director of Interventional Cardiology Professor of Medicine Massachusetts

More information

Platelet function testing to guide P2Y 12 -inhibitor treatment in ACS patients after PCI: insights from a national program in Hungary

Platelet function testing to guide P2Y 12 -inhibitor treatment in ACS patients after PCI: insights from a national program in Hungary Platelet function testing to guide P2Y 12 -inhibitor treatment in ACS patients after PCI: insights from a national program in Hungary Dániel Aradi MD PhD Interventional Cardiologist Assistant professor

More information

IABP SHOCK II trial:

IABP SHOCK II trial: IABP SHOCK II trial: Randomized comparison of intraaortic balloon counterpulsation versus optimal medical therapy in addition to early revascularization in acute myocardial infarction complicated by cardiogenic

More information

Komplexe Koronarintervention heute: Von Syntax zu bioresorbierbaren Stents

Komplexe Koronarintervention heute: Von Syntax zu bioresorbierbaren Stents Komplexe Koronarintervention heute: Von Syntax zu bioresorbierbaren Stents Prof. Dr. med. Julinda Mehilli Medizinische Klinik und Poliklinik I Klinikum der Universität München Campus Großhadern Key Factors

More information

Clinical case in perspective. Cases from Poland

Clinical case in perspective. Cases from Poland Clinical case in perspective Cases from Poland Assoc. Prof. Jacek Legutko, MD, PhD President-Elect of the Association for Percutaneous Cardiovascular Interventions of the Polish Cardiac Society Institute

More information

Trial Update- TOTAL. Jonathan Byrne

Trial Update- TOTAL. Jonathan Byrne Trial Update- TOTAL Jonathan Byrne No conflicts of interest Background- rationale for thrombectomy Major Limitation of primary PCI: distal embolisation and reduced flow Stonel JACC 2002;39:591-7 Henriques

More information

Acute Coronary Syndrome (ACS) is the consequence of

Acute Coronary Syndrome (ACS) is the consequence of Clinical Practice Pharmaco-invasive Therapy for STEMI; The Most Suitable STEMI Reperfusion Therapy for Transferred Patients in Thailand Pradub Sukhum, MD. 1 1 Division of Cardiovascular Medicine, Bangkok

More information

FFR-guided Jailed Side Branch Intervention

FFR-guided Jailed Side Branch Intervention FFR-guided Jailed Side Branch Intervention - Pressure wire in Bifurcation lesions - Bon-Kwon Koo, MD, PhD Seoul National University Hospital, Seoul, Korea Bifurcation Lesions Bifurcation Lesions Still

More information

Controversies in Cardiac Surgery

Controversies in Cardiac Surgery Controversies in Cardiac Surgery 3 years after SYNTAX : Percutaneous Coronary Intervention for Multivessel / Left main stem Coronary artery disease Pro ESC Congress 2010, 28 August 1 September Stockholm

More information

North Wales Cardiac Network Guidelines on oral antiplatelet therapy in cardiovascular disease

North Wales Cardiac Network Guidelines on oral antiplatelet therapy in cardiovascular disease Guidelines on oral antiplatelet therapy in cardiovascular disease This guidance should be considered as one part of the wider therapeutic management of patients. The indication for antiplatelet therapy

More information

Are Asian Patients Different? - Updates Of Biomatrix Experience In Regional Settings: BEACON II (3 Yr F up) &

Are Asian Patients Different? - Updates Of Biomatrix Experience In Regional Settings: BEACON II (3 Yr F up) & Are Asian Patients Different? - Updates Of Biomatrix Experience In Regional Settings: BEACON II (3 Yr F up) & Biomatrix TM Single Center Experience (Indonesia)(Final 5 Yr F up) T. Santoso University of

More information

The Role of DHMC as an ST Elevation Myocardial Infarction Receiving Center in a Regional STEMI Care Network:

The Role of DHMC as an ST Elevation Myocardial Infarction Receiving Center in a Regional STEMI Care Network: The Role of DHMC as an ST Elevation Myocardial Infarction Receiving Center in a Regional STEMI Care Network: Nathaniel Niles, MD CREST Symposium November 7th, 28 STEMI = Acute Coronary Thrombosis STEMI

More information

Safety of Single- Versus Multi-vessel Angioplasty for Patients with AMI and Multi-vessel CAD

Safety of Single- Versus Multi-vessel Angioplasty for Patients with AMI and Multi-vessel CAD Safety of Single- Versus Multi-vessel Angioplasty for Patients with AMI and Multi-vessel CAD Mun K. Hong, MD Associate Professor of Medicine Director, Cardiovascular Intervention and Research Weill Cornell

More information

When Aspiration Thrombectomy Does Not Work? A A R O N W O N G N A T I O N A L H E A R T C E N T R E S I N G A P O R E

When Aspiration Thrombectomy Does Not Work? A A R O N W O N G N A T I O N A L H E A R T C E N T R E S I N G A P O R E When Aspiration Thrombectomy Does Not Work? A A R O N W O N G N A T I O N A L H E A R T C E N T R E S I N G A P O R E Thrombus in STEMI Over 70% of STEMI patients has angiographic evidence of thrombus

More information

Primary PCI in patients with STEMI Abbott Vascular. All rights reserved.

Primary PCI in patients with STEMI Abbott Vascular. All rights reserved. Primary PCI in patients with STEMI Primary PCI in patients with STEMI Agenda 2 Primary PCI in patients with STEMI Definition: angioplasty ± stenting without prior or concomitant fibrinolytic therapy Objectives

More information

Revived indications for thrombus aspiration during primary PCI: Unanswered questions after TAPAS

Revived indications for thrombus aspiration during primary PCI: Unanswered questions after TAPAS Revived indications for thrombus aspiration during primary PCI: Unanswered questions after TAPAS Gregg W. Stone MD Columbia University Medical Center Cardiovascular Research Foundation Disclosures Gregg

More information

Presented by Prof David Erlinge, MD, PhD, On behalf of the RAPID MI-ICE Investigators

Presented by Prof David Erlinge, MD, PhD, On behalf of the RAPID MI-ICE Investigators Cold saline and endovascular cooling induces rapid hypothermia before reperfusion in STEMI patients treated with primary PCI, is safe and reduces infarct size with a scattered myocardial salvage Presented

More information

Quality Standards for Patients Treated by PCI. Peter F Ludman

Quality Standards for Patients Treated by PCI. Peter F Ludman Quality Standards for Patients Treated by PCI Peter F Ludman NO CONFLICT OF INTEREST TO DECLARE Quality Standards for Patients treated by PCI Caution about standards Overall Structure for assessing outcomes

More information

Can Angiographic Complete Revascularization Improve Outcomes for Patients with Decreased LV Function? NO!

Can Angiographic Complete Revascularization Improve Outcomes for Patients with Decreased LV Function? NO! Can Angiographic Complete Revascularization Improve Outcomes for Patients with Decreased LV Function? NO! Young-Hak Kim, MD, PhD Heart Institute, University of Ulsan College of Medicine Asan Medical Center,

More information

Reconciling the Results of the Randomized Trials

Reconciling the Results of the Randomized Trials Management of Stable Angina in Multivessel Disease: Reconciling the Results of the Randomized Trials Eric A. Cohen MD, FRCPC Schulich Heart Centre Sunnybrook Health Sciences Centre Toronto ON ACC Rockies

More information

STEMI ST Elevation Myocardial Infarction

STEMI ST Elevation Myocardial Infarction STEMI ST Elevation Myocardial Infarction Breakout Session One Moderators: Quinn Capers IV, MD and Scott M. Lilly, MD, PhD Cases Presented by: Umair S. Ahmad, MD 1 Outline 1. Multivessel Revascularization

More information

Intervention: How and to which extent is technology helping us?

Intervention: How and to which extent is technology helping us? Cardiological Society of India Congress 12th February 2016 Chennai, India Intervention: How and to which extent is technology helping us? SIMONE BISCAGLIA MD CARDIOVASCULAR INSTITUTE, FERRARA, ITALY Introduction

More information

Issues in the Management of Diabetic Patients with Cardiovascular Disease

Issues in the Management of Diabetic Patients with Cardiovascular Disease Issues in the Management of Diabetic Patients with Cardiovascular Disease Elliot Rapaport, MD December 13, 2008 1 Hyperglycemia and Acute Coronary Syndromes 2 Effect of Hyperglycemia in STEMI Impairs microvascular

More information

Coronary Interventions Indications, Treatment Options and Outcomes

Coronary Interventions Indications, Treatment Options and Outcomes Coronary Interventions Indications, Treatment Options and Outcomes A talk should be like a woman s skirt long enough to cover the subject, but short enough to keep it interesting. Coronary anatomy Physiology

More information

Non merci! Revascularisation complète à la phase aigue de l infarctus? 8 e Cardiorun, La Réunion, 1 er octobre Gilles Rioufol, MD, PhD

Non merci! Revascularisation complète à la phase aigue de l infarctus? 8 e Cardiorun, La Réunion, 1 er octobre Gilles Rioufol, MD, PhD Revascularisation complète à la phase aigue de l infarctus? Non merci! 8 e Cardiorun, La Réunion, 1 er octobre 2014 Gilles Rioufol, MD, PhD Interventional cardiology dpt Cardiovascular Hospital - Lyon

More information

Resolute in Bifurcation Lesions: Data from the RESOLUTE Clinical Program

Resolute in Bifurcation Lesions: Data from the RESOLUTE Clinical Program Resolute in Bifurcation Lesions: Data from the RESOLUTE Clinical Program Prof. Ran Kornowski, MD, FESC, FACC Director - Division of Interventional Cardiology Rabin Medical Center and Tel Aviv University,

More information

STEMI Presentation and Case Discussion. Case #1

STEMI Presentation and Case Discussion. Case #1 STEMI Presentation and Case Discussion Scott M Lilly MD PhD, Interventional Cardiology The Ohio State University Contemporary Multidisciplinary Cardiovascular Conference Orlando, Florida September 17 th,

More information

Guideline for STEMI. Reperfusion at a PCI-Capable Hospital

Guideline for STEMI. Reperfusion at a PCI-Capable Hospital MANSOURA. 2015 Guideline for STEMI Reperfusion at a PCI-Capable Hospital Mahmoud Yossof MANSOURA 2015 Reperfusion Therapy for Patients with STEMI *Patients with cardiogenic shock or severe heart failure

More information

Myocardial Infarction In Dr.Yahya Kiwan

Myocardial Infarction In Dr.Yahya Kiwan Myocardial Infarction In 2007 Dr.Yahya Kiwan New Definition Of Acute Myocardial Infarction The term of myocardial infarction should be used when there is evidence of myocardial necrosis in a clinical setting

More information

Assessing Myocardium at Risk: Applying SYNTAX

Assessing Myocardium at Risk: Applying SYNTAX Assessing Myocardium at Risk: Applying SYNTAX Farouc Jaffer MD PhD FSCAI FACC FAHA Associate Professor of Medicine, Harvard Medical School Director, CAD Program and Chronic Total Occlusion PCI Program

More information

Impact of Thromboaspiration during Primary PCI on infarcted segmental myocardial function: a Tissue Doppler imaging evaluation. EXPIRA Trial substudy.

Impact of Thromboaspiration during Primary PCI on infarcted segmental myocardial function: a Tissue Doppler imaging evaluation. EXPIRA Trial substudy. Impact of Thromboaspiration during Primary PCI on infarcted segmental myocardial function: a Tissue Doppler imaging evaluation. EXPIRA Trial substudy. GENNARO SARDELLA, MD, FACC,FESC; MASSIMO MANCONE,

More information